Joseph Kiss
Pittsburgh, PANPI 1871567065
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Sanofi at 58.1% of the total. Reporting peaked in 2020 at $21,398 and has fallen 66.4% since, to $7,199 in 2024.
Across 88 payments — averaging $848.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$43K
- Haemonetics Corporation$14K
- Sanofi-aventis U.S. LLC$9K
- Grifols Shared Services North America, Inc.$5K
- Kaneka Medical America LLC$3K
- AstraZeneca$190
- plus $158 from 4 others
Across 15 payments — averaging $11,986 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$82K
- Sanofi$59K
- Bioverativ Therapeutics Inc.$28K
- Ablynx NV$11K
What the payments were for
- Consulting fees$42,30957%
- Speaking & faculty fees$23,57832%
- Travel & lodging$6,7049%
- Food & beverage$2,0743%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 51 | $43,359 |
| Haemonetics Corporation | 6 | $13,516 |
| Sanofi-aventis U.S. LLC | 10 | $9,124 |
| Grifols Shared Services North America, Inc. | 10 | $5,221 |
| Kaneka Medical America LLC | 1 | $3,097 |
| AstraZeneca | 6 | $190 |
| Grifols Biologicals LLC | 1 | $95 |
| Johnson & Johnson | 1 | $26 |
| Novartis | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CABLIVI$17,270
- Plasma$8,766
- TEG6s HEMOSTASIS SYSTEM$4,750
- Albutein$4,008
- LIPOSORBER$3,097
- ENJAYMO$2,790
- Flebogamma DIF$1,028
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.